Starting Wednesday, anybody aged 65 years old or over who tests positive using a COVID-19 rapid test will be eligible for the oral antiviral drug Paxlovid if their result is confirmed by a doctor, according to the Central Epidemic Command Center (CECC).
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
-
Business
U.S. dollar down in Taipei trading
05/25/2026 10:39 AM -
Society
Taiwan headline news
05/25/2026 10:14 AM -
Business
Taiwan shares open higher
05/25/2026 09:24 AM -
Politics
KMT's Cheng to visit U.S. June 1, with stops in New York, D.C., Boston: Source
05/24/2026 08:10 PM -
Politics
Taiwan, Chinese coast guard vessels in standoff near Dongsha Island
05/24/2026 06:12 PM